What is TTRX's total debt?

TTRX (TTRX) reported total debt of $6.01M in Q1 2026.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

TTRX TTRX Total debt

Total debt at other companies

Bausch Health CompaniesBHC

$20.76B-3.5%

Journey Medical CorporationDERM

$25.47M+1.2%

PTH

Pelthos Therapeutics Inc.PTHS

$29.65M—

Celldex TherapeuticsCLDX

$1.91M-44.3%

Arcutis Biotherapeutics, Inc.ARQT

$114.67M+3.5%

Regeneron PharmaceuticalsREGN

——

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Calculated from TTRX’s reported figures.

$5.9Mlong term debt=$6.01M

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's total debt?: TTRX (TTRX) reported total debt of $6.01M in Q1 2026.
What does total debt mean?: Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.